Futura Medical plc (FRA:GYX)

Market Cap	8.39M -82.9%
Revenue (ttm)	9.25M -5.6%
Net Income	-7.34M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	27,482
Open	0.0095
Previous Close	0.0095
Day's Range	0.0095 - 0.0095
52-Week Range	0.0040 - 0.1800
Beta	n/a
RSI	48.60
Earnings Date	Apr 10, 2026

About Futura Medical

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Pharmaceutical Preparations
• Founded: 2001
• Employees: 14
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GYX

Financial Performance

Financial numbers in GBP